Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fersht

Showing results (491-500 of 593) with videos related to

Pageof 60
Sort By:
Protein Science : a Publication of the Protein Society|September 30, 2010
Stabilization of mutant p53 via alkylation of cysteines and effects on DNA bindingJoel L Kaar, Nicolas Basse, Andreas C Joerger, et al.
Journal of Molecular Biology|June 22, 2005
Simulation and experiment conspire to reveal cryptic intermediates and a slide from the nucleation-condensation to framework mechanism of foldingGeorge W N White, Stefano Gianni, J Gunter Grossmann, et al.
Cancers|November 27, 2024
Do Patient-Reported Outcome Measures (PROMs) Used Within Radiotherapy Clinical Trials Reflect the Impact of Treatment?Danielle Fairweather, Rachel M Taylor, Laura Allington, et al.
Biochemistry|July 7, 1999
The solution structure of oxidized Escherichia coli cytochrome b562F Arnesano, L Banci, I Bertini, et al.
Biochemistry|April 4, 2001
The binding of bis-ANS to the isolated GroEL apical domain fragment induces the formation of a folding intermediate with increased hydrophobic surface not observed in tetradecameric GroELA L Smoot, M Panda, B T Brazil, et al.
Journal of Neuro-Oncology|February 5, 2016
Craniospinal irradiation with concomitant and adjuvant temozolomide--a feasibility assessment of toxicity in patients with glioblastoma with a PNET componentBen O'Leary, Henry C Mandeville, Naomi Fersht, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 1999
Hot-spot mutants of p53 core domain evince characteristic local structural changesK B Wong, B S DeDecker, S M Freund, et al.
Cell Cycle (Georgetown, Tex.)|December 6, 2003
The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to deathMichelle Ferguson, M Gloria Luciani, Lee Finlan, et al.
Protein Science : a Publication of the Protein Society|July 16, 2008
The novel p53 isoform "delta p53" is a misfolded protein and does not bind the p21 promoter siteMaria M García-Alai, Henning Tidow, Eviatar Natan, et al.
Biophysical Journal|April 22, 2008
Tumor suppressor p53 slides on DNA with low friction and high stabilityAnahita Tafvizi, Fang Huang, Jason S Leith, et al.
Pageof 60

Showing results (491-500 of 593) with videos related to

Sort By:
Pageof 60
Protein Science : a Publication of the Protein Society|September 30, 2010
Stabilization of mutant p53 via alkylation of cysteines and effects on DNA bindingJoel L Kaar, Nicolas Basse, Andreas C Joerger, et al.
Journal of Molecular Biology|June 22, 2005
Simulation and experiment conspire to reveal cryptic intermediates and a slide from the nucleation-condensation to framework mechanism of foldingGeorge W N White, Stefano Gianni, J Gunter Grossmann, et al.
Cancers|November 27, 2024
Do Patient-Reported Outcome Measures (PROMs) Used Within Radiotherapy Clinical Trials Reflect the Impact of Treatment?Danielle Fairweather, Rachel M Taylor, Laura Allington, et al.
Biochemistry|July 7, 1999
The solution structure of oxidized Escherichia coli cytochrome b562F Arnesano, L Banci, I Bertini, et al.
Biochemistry|April 4, 2001
The binding of bis-ANS to the isolated GroEL apical domain fragment induces the formation of a folding intermediate with increased hydrophobic surface not observed in tetradecameric GroELA L Smoot, M Panda, B T Brazil, et al.
Journal of Neuro-Oncology|February 5, 2016
Craniospinal irradiation with concomitant and adjuvant temozolomide--a feasibility assessment of toxicity in patients with glioblastoma with a PNET componentBen O'Leary, Henry C Mandeville, Naomi Fersht, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 1999
Hot-spot mutants of p53 core domain evince characteristic local structural changesK B Wong, B S DeDecker, S M Freund, et al.
Cell Cycle (Georgetown, Tex.)|December 6, 2003
The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to deathMichelle Ferguson, M Gloria Luciani, Lee Finlan, et al.
Protein Science : a Publication of the Protein Society|July 16, 2008
The novel p53 isoform "delta p53" is a misfolded protein and does not bind the p21 promoter siteMaria M García-Alai, Henning Tidow, Eviatar Natan, et al.
Biophysical Journal|April 22, 2008
Tumor suppressor p53 slides on DNA with low friction and high stabilityAnahita Tafvizi, Fang Huang, Jason S Leith, et al.
Pageof 60